Johnson & Johnson's $16.6 billion takeover offer for cardiac pump manufacturer Abiomed looks set to be the largest medtech acquisition of the year, and other buyers are unlikely to enter a bidding war ...
J&J invests in MedTech and Innovative Medicine, enhancing its diverse healthcare portfolio. It uses its robust cash flow and a strong balance sheet for strategic acquisitions. Recent purchases aim to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback